11 II-1 Introduction ?, p.11 ,
13 II-2-1 Définition et facteurs de risque ?, p.13 ,
Natural resolution of inflammation, Periodontology 2000, vol.12, issue.Suppl 1, pp.149-164, 2000. ,
DOI : 10.1111/prd.12034
Ageing gender-specific "Biomarkers of Homeostasis", to protect ourselves against the diseases of the old age, Immunity & Ageing, vol.11, issue.1 ,
DOI : 10.1016/j.cbpa.2005.12.016
Regulation of human neutrophil apoptosis and lifespan in health and disease, J Cell Death, vol.7, pp.15-23, 2014. ,
Mechanisms for transcellular diapedesis: probing and pathfinding by `invadosome-like protrusions', Journal of Cell Science, vol.122, issue.17, pp.3025-3060, 2009. ,
DOI : 10.1242/jcs.047522
Dynamic process of phagocytosis and forms of macrophage cell death induced by ingestion of apoptotic neutrophils, Science China Life Sciences, vol.8, issue.10 ,
DOI : 10.1007/s11427-014-4726-y
François Leballe and Col. Phospholipases A2 et pathologie inflammatoire : consensus et nouveaux concepts. médecine, sciences, vol.12, pp.323-355, 1995. ,
Termination of Immune Activation: An Essential Component of Healthy Host Immune Responses, Journal of Innate Immunity, vol.6, issue.6, 2014. ,
DOI : 10.1159/000363449
Cell and tissue regenration Basic Pathology ,
Aspect morphologique de la réaction inflammatoire chronique, 2007. ,
International workshop for a classification of periodontal diseases and conditions, Annals of Period, The american academy of periodontology, pp.4-23, 1999. ,
Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions, Periodontology 2000, vol.59, issue.1, pp.216-248, 1997. ,
DOI : 10.1007/BF01539135
Microbial complexes in subgingival plaque, Journal of Clinical Periodontology, vol.11, issue.2, pp.134-144, 1998. ,
DOI : 10.1111/j.1600-051X.1993.tb00694.x
Prevalence, extent, severity and progression of periodontal disease, Periodontology 2000, vol.58, issue.1, pp.57-71, 1999. ,
DOI : 10.2307/2348088
Microbiology of aggressive periodontitis, Periodontology 2000, vol.42, issue.Suppl. 11, pp.46-78, 2000. ,
DOI : 10.1111/prd.12016
Immunobiological activities of a 55-kilodalton cell surface protein of Prevotella intermedia ATCC 25611, Infect Immun, vol.62, issue.6, pp.2459-69, 1994. ,
Cytokine-inducing components of periodontopathogenic bacteria, Journal of Periodontal Research, vol.26, issue.6, pp.393-407, 1996. ,
DOI : 10.1016/0006-291X(90)91550-C
Natural history of periodontal disease in man. Rapid, moderate and no loss of attachment in Sri Lankan laborers 14 to 46 years of age, Journal of Clinical Periodontology, vol.11, issue.5, pp.431-440, 1986. ,
DOI : 10.1111/j.1600-051X.1986.tb01487.x
Analysis of saliva for periodontal diagnosis. A review, Journal of Clinical Periodontology, vol.27, issue.7, pp.453-465, 2000. ,
DOI : 10.1034/j.1600-051x.2000.027007453.x
The neutrophil mecansims of controlling periodontal bacteria ,
Pathogenesis of inflammatory peridodontal disease. A summary of current work, Lab invest, vol.33, pp.235-249, 1976. ,
Dimensions and Relations of the Dentogingival Junction in Humans, Journal of Periodontology, vol.32, issue.3, pp.261-267, 1961. ,
DOI : 10.1902/jop.1961.32.3.261
Collagen Resorption by Periodontal Ligament Fibroblasts at the Hard Tissue-Ligament Interfaces of the Mouse Periodontium, Journal of Periodontology, vol.51, issue.8, pp.429-461, 1980. ,
DOI : 10.1902/jop.1980.51.8.429
Inflammation and Bone Loss in Periodontal Disease, Journal of Periodontology, vol.79, issue.8s, pp.1569-74, 2008. ,
DOI : 10.1902/jop.2008.080233
Parodontites agressives : prévalence bactérienne et sonde ADN, p.2, 2009. ,
Development of a Classification System for Periodontal Diseases and Conditions, Annals of Periodontology, vol.4, issue.1, pp.1-6, 1999. ,
DOI : 10.1902/annals.1999.4.1.1
Early Onset Periodontitis in the United States of America, Journal of Periodontology, vol.62, issue.10, pp.608-616, 1991. ,
DOI : 10.1902/jop.1991.62.10.608
Early-Onset Periodontitis: Progression of Attachment Loss During 6 Years, Journal of Periodontology, vol.67, issue.10, pp.968-75, 1996. ,
DOI : 10.1902/jop.1996.67.10.968
Bactériologie buccodentaire, Edition Masson, pp.42-45, 1994. ,
Periodontal microbiology, pp.96-112, 2002. ,
Susceptibility of MRSA biofilms to denture-clensing agents, Microbiol let, vol.291, pp.241-246, 2009. ,
Commentary: periodontitis is characterized by an immunoinflammatory host-mediated destruction of bone and connective tissues that support the teeth, J Periodontol. 2014, vol.85, issue.4, pp.509-520 ,
Clinical Innovations in Managing Inflammation and Periodontal Diseases: The Workshop on Inflammation and Periodontal Diseases, Journal of Periodontology, vol.79, issue.8s, pp.1609-1611, 2008. ,
DOI : 10.1902/jop.2008.080305
Primary prevention of periodontitis: managing gingivitis, Journal of Clinical Periodontology, vol.3, issue.Suppl. 16, 2015. ,
DOI : 10.1111/jcpe.12366
Effect of professional mechanical plaque removal on secondary prevention of periodontitis and the complications of gingival and periodontal preventive measures, Journal of Clinical Periodontology, vol.8, 2015. ,
DOI : 10.1111/jcpe.12367
Prevention and treatment of periodontal diseases in primary care. Evid Based Dent, pp.68-77, 2014. ,
Periodontal Debridement: Still the Treatment of Choice, Journal of Evidence Based Dental Practice, vol.14, pp.33-41 ,
DOI : 10.1016/j.jebdp.2014.02.007
Prognostic factors in the treatment of generalized aggressive periodontitis: I. Clinical features and initial outcome, Journal of Clinical Periodontology, vol.29, issue.(Suppl 3), pp.663-670, 2006. ,
DOI : 10.1111/j.1600-051X.2006.00966.x
Le concept thérapeuthique de la décontamination globale, Titane, Septembre, vol.5, pp.3-21, 2008. ,
Adjunctive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: a randomized placebo-controlled clinical trial, Journal of Clinical Periodontology, vol.63, issue.10, pp.1096-1107, 2005. ,
DOI : 10.1034/j.1600-051X.1999.260507.x
A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution, Histochemistry and Cell Biology, vol.171, issue.4, pp.305-321, 2004. ,
DOI : 10.1007/s00418-004-0695-8
Natural resolution of inflammation, Annu Rev Pathol, vol.3, pp.279-312, 2008. ,
Polyunsaturated fatty acids, inflammation, and inflammatory diseases., Am J Clin Nutr, vol.83, pp.1505-1524, 2006. ,
DOI : 10.1037/12065-004
A NEW DEFICIENCY DISEASE PRODUCED BY THE RIGID EXCLUSION OF FAT FROM THE DIET, Nutrition Reviews, vol.31, issue.8, pp.345-67, 1929. ,
DOI : 10.1111/j.1753-4887.1973.tb06008.x
Lipid mediator class switching during acute inflammation: signals in resolution, Nature Immunology, vol.2, issue.7, pp.612-631, 2001. ,
DOI : 10.1038/89759
Inflammatory Resolution: new opportunities for drug discovery, Nature Reviews Drug Discovery, vol.92, issue.5, pp.401-417, 2004. ,
DOI : 10.1172/JCI200318012
Pro-resolving lipid mediators ar lead for resolution physiology, Nature, pp.92-101, 2014. ,
Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2???Nonsteroidal Antiinflammatory Drugs and Transcellular Processing, The Journal of Experimental Medicine, vol.1437, issue.8, pp.1197-204, 2000. ,
DOI : 10.1056/NEJM199704033361401
RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis, The FASEB Journal, 2005. ,
DOI : 10.1096/fj.05-4724fje
Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1, The Journal of Experimental Medicine, vol.285, issue.5, pp.713-735, 2005. ,
DOI : 10.1074/jbc.271.37.22663
Lipid mediator class switching during acute inflammation: signals in resolution, Nature Immunology, vol.2, issue.7, pp.612-631, 2001. ,
DOI : 10.1038/89759
Mediator lipidomics, Prostaglandins & Other Lipid Mediators, vol.77, issue.1-4, pp.4-14, 2005. ,
DOI : 10.1016/j.prostaglandins.2004.09.016
Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration, British Journal of Pharmacology, vol.126, issue.1, pp.43-52, 2004. ,
DOI : 10.1038/sj.bjp.0705912
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1575273
Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus, British Journal of Pharmacology, vol.76, issue.69, pp.200-215, 2008. ,
DOI : 10.1038/sj.bjp.0707489
Cyclooxygenase Inhibitors ,
DOI : 10.1007/978-1-4684-4946-4_56
Mechanism of Action, and Clinical Applications, Biochemistry Plenum, pp.583-91, 1985. ,
Anti-Inflammatory Actions of Neuroprotectin D1/Protectin D1 and Its Natural Stereoisomers: Assignments of Dihydroxy-Containing Docosatrienes, The Journal of Immunology, vol.176, issue.3, pp.1848-59, 2006. ,
DOI : 10.4049/jimmunol.176.3.1848
A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease, Journal of Clinical Investigation, vol.115, issue.10, pp.2774-83, 2005. ,
DOI : 10.1172/JCI25420DS1
Anti-Inflammatory Actions of Neuroprotectin D1/Protectin D1 and Its Natural Stereoisomers: Assignments of Dihydroxy-Containing Docosatrienes, The Journal of Immunology, vol.176, issue.3, pp.1848-59, 2006. ,
DOI : 10.4049/jimmunol.176.3.1848
Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination, Journal of Internal Medicine, vol.115, issue.Suppl 1, pp.15-24, 2010. ,
DOI : 10.1111/j.1365-2796.2010.02235.x
Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.35, issue.5, pp.1123-1156 ,
DOI : 10.1161/ATVBAHA.115.305324
Impact of Resolvin E1 on Murine Neutrophil Phagocytosis in Type 2 Diabetes, Infection and Immunity, vol.83, issue.2, pp.792-801 ,
DOI : 10.1128/IAI.02444-14
Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function, Journal of Molecular and Cellular Cardiology, vol.84, pp.24-35, 2015. ,
DOI : 10.1016/j.yjmcc.2015.04.003
Resolvin D2 recovers neural injury by suppressing inflammatory mediators expression in lipopolysaccharide-induced Parkinson's disease rat model, Biochemical and Biophysical Research Communications, vol.460, issue.3, pp.799-805, 2015. ,
DOI : 10.1016/j.bbrc.2015.03.109
Aspirin-Triggered Resolvin D1 Treatment Enhances Resolution of Hyperoxic Acute Lung Injury, AmJ Respir Cell Mol Biol, 2015. ,
Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse, Brain, Behavior, and Immunity, vol.47, 2015. ,
DOI : 10.1016/j.bbi.2015.01.001
Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction, Basic Research in Cardiology, vol.14, issue.6, p.444, 2014. ,
DOI : 10.1007/s00395-014-0444-7
Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis, Proceedings of the National Academy of Sciences, vol.102, issue.21, pp.7671-7676, 2005. ,
DOI : 10.1073/pnas.0409271102
RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodon-titis ,
Resolvin E1 Regulates Inflammation at the Cellular and Tissue Level and Restores Tissue Homeostasis In Vivo, J Immunol, vol.179, pp.7021-7029, 2007. ,
La CRP est-elle plus qu'un marqueur de l'inflammation ? Néphrologie, pp.7-337, 2003. ,